Name (Synonyms) | Correlation | |
---|---|---|
D014777 | Virus Diseases NIH | 0.12 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
To evaluate the efficacy and safety of Anluohuaxian in blocking the progression of pulmonary fibrosis and improving lung function in patients with COVID-19.
Description: Changes in ground-glass shadows, interstitial or air nodules found on high-resolution computer tomography
Measure: Changes in high-resolution computer tomography of the lung Time: 3 monthsDescription: St. George's Hospital Respiratory Questionnaire range from 0 to 100. 0 stands for no impact on life and 100 stands for extreme impact on life.
Measure: Changes in the scores of the St. George's Hospital Respiratory Questionnaire Time: 3 monthsDescription: mMRC score range from 0 to 4. 0 stands for wheezing only when exercising hard and 4 stands for severe breathing difficulties.
Measure: Changes in modified British Medical Research Council Dyspnea Scale (mMRC) scores Time: 3 monthsDescription: Adult male vital capacity is about 3,500 ml and female is about 2,500 ml.
Measure: Changes in vital capacity of the lung Time: 3 months